Balchem (BCPC) Common Equity (2010 - 2026)

Balchem (BCPC) has 17 years of Common Equity data on file, last reported at $1.3 billion in Q1 2026.

• Quarterly Common Equity rose 6.32% year-over-year to $1.3 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.3 billion (up 6.32% YoY) and the FY2025 annual result came in at $1.3 billion, up 9.35% from the prior year.
• Common Equity rose to $1.3 billion in Q1 2026 per BCPC's latest filing, from $1.3 billion in the prior quarter.
• Across five years, Common Equity topped out at $1.3 billion in Q3 2025 and bottomed at $873.7 million in Q1 2022.
• The 5-year median for Common Equity is $1.1 billion (2024), against an average of $1.1 billion.
• The widest annual swing landed in 2022, when Common Equity grew 0.77%; it then rose 14.82% in 2024.
• Tracing BCPC's Common Equity over 5 years: stood at $938.3 million in 2022, then gained by 12.33% to $1.1 billion in 2023, then grew by 9.1% to $1.1 billion in 2024, then climbed by 9.35% to $1.3 billion in 2025, then rose by 2.2% to $1.3 billion in 2026.
• Per Business Quant, the three latest BCPC Common Equity figures stand at $1.3 billion (Q1 2026), $1.3 billion (Q4 2025), and $1.3 billion (Q3 2025).

Peer Comparison